Sun Pharma gains on price hike report by unit

Reuters Market Eye - Shares in Sun Pharmaceutical Industries Ltd gain 4 percent after Nomura said URL Pharma, the unit it acquired from Takeda Pharmaceutical Co Ltd , has significantly raised prices of a drug, dealers say.

Nomura said in a report that "URL Pharma has taken a significant price hike (15 times) in doxycycline hyclate. We believe Sun could clock annual revenue of USD100mn from the product based on the current run rate."

(Reporting by Abhishek Vishnoi)